An oral second-generation proteasome inhibitor oprozomib significantly inhibits lung cancer in a p53 independent manner in vitro.
Acta Biochim Biophys Sin (Shanghai)
; 51(10): 1034-1040, 2019 Sep 06.
Article
in En
| MEDLINE
| ID: mdl-31518420
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oligopeptides
/
Proteasome Inhibitors
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Acta Biochim Biophys Sin (Shanghai)
Journal subject:
BIOFISICA
/
BIOQUIMICA
Year:
2019
Document type:
Article
Affiliation country:
China